Overview
- Emphasizes emerging therapeutic options
- Discusses the practical applications of novel molecular targeted agents
- Conveys recent advances in the understanding of molecular pathogenesis
- Covers all major types of neuroendocrine tumors
- Includes supplementary material: sn.pub/extras
Part of the book series: Current Clinical Oncology (CCO)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (14 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management.
In this volume, an outstanding group of the world’s leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.
Reviews
From the reviews:
“This text is a welcome addition to the Current Clinical Oncology series … . The book is extremely broad in its coverage and does include just about all of the neuroendocrine tumours … . as a handy lightweight reference it is an extremely useful addition both to the hospital library and the personal library of clinicians who manage these tumours. … it is a very readable reference book and a great asset to the library … .” (Nick Reed, Oncology News, Vol. 6 (6), January/February, 2012)
“Individual chapters are discussing the epidemiology and pathology of neuroendocrine tumors as well as problems of multiple endocrine neoplasia (MEN syndrome). Special attention is paid to other genetic syndromes such as von Hippel Lindau syndrome, neurofibromatosis, tuberous sclerosis and paraganglioma-phaechromocytoma. … the editors and authors hope that their work will help to demystify some important misconceptions regarding neuroendocrione tumors and that it maz help to improve the treatment of patients and families affected by this disease.” (Endocrine Regulations, January, 2012)
“The book is intended for both medical and surgical specialists with an interest in neuroendocrine tumors. The depth and presentation of the material is excellent for surgical/medical trainees as well as practicing surgeons/internists. … This book addresses the entire spectrum of neuroendocrine tumor management from epidemiology to diagnosis, staging, and treatment. … The way this book discusses the entire breadth of neuroendocrine tumors in an easily readable yet remarkably informative manner is refreshing.” (Timothy Platz, Doody’s Book Reviews, November, 2011)
Editors and Affiliations
Bibliographic Information
Book Title: Neuroendocrine Tumors
Editors: James C. Yao, Paulo M. Hoff, Ana O. Hoff
Series Title: Current Clinical Oncology
DOI: https://doi.org/10.1007/978-1-60327-997-0
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-60327-996-3Published: 15 July 2011
Softcover ISBN: 978-1-61779-756-9Published: 22 August 2013
eBook ISBN: 978-1-60327-997-0Published: 12 July 2011
Series ISSN: 2364-1134
Series E-ISSN: 2364-1142
Edition Number: 1
Number of Pages: XII, 268
Topics: Oncology, Surgical Oncology, Endocrinology, Surgery, Gastroenterology